Gynecologic Oncology Updates: Expert Perspective on Key Trial Findings

122 views
October 17, 2024

Chapters

Low-Grade Ovarian Cancer Advancements

00:00

PARP Inhibitors & ctDNA Studies in Ovarian Cancer

02:03

Advanced Ovarian Cancer: Yale Ixabepilone Trial

03:45

RUBY Trial: Endometrial Cancer & Dostarlimab Approval

04:37

GOG-3041: Durvalumab & PARP Inhibitors in Endometrial Cancer

06:38

PARP Inhibitors' Role in Uterine & Cervical Cancer

07:31

Surgical Trials & Mirvetuximab Use in Ovarian & Endometrial Cancer

09:21

0 Comments
Login to view comments. Click here to Login